The continuing search for a succinylcholine replacement

Editorial

James E Caldwell. Anesthesiology. 2004 Apr.

. 2004 Apr;100(4):763-4.

doi: 10.1097/00000542-200404000-00002.

No abstract available

Comment in

GW280430A: pharmacodynamics and potential adverse effects.
Lien CA, Belmont MR, Heerdt PM. Lien CA, et al. Anesthesiology. 2005 Apr;102(4):861-2; author reply 862-3. doi: 10.1097/00000542-200504000-00025. Anesthesiology. 2005. PMID: 15791118 No abstract available.
GW280430A.
Geldner GF, Blobner M. Geldner GF, et al. Anesthesiology. 2005 Apr;102(4):861; author reply 862-5. doi: 10.1097/00000542-200504000-00024. Anesthesiology. 2005. PMID: 15791119 No abstract available.

Clinical pharmacology of GW280430A in humans.
Belmont MR, Lien CA, Tjan J, Bradley E, Stein B, Patel SS, Savarese JJ. Belmont MR, et al. Anesthesiology. 2004 Apr;100(4):768-73. doi: 10.1097/00000542-200404000-00004. Anesthesiology. 2004. PMID: 15087609
Preclinical pharmacology of GW280430A (AV430A) in the rhesus monkey and in the cat: a comparison with mivacurium.
Savarese JJ, Belmont MR, Hashim MA, Mook RA Jr, Boros EE, Samano V, Patel SS, Feldman PL, Schultz JA, McNulty M, Spitzer T, Cohn DL, Morgan P, Wastila WB. Savarese JJ, et al. Anesthesiology. 2004 Apr;100(4):835-45. doi: 10.1097/00000542-200404000-00013. Anesthesiology. 2004. PMID: 15087618
Cardiopulmonary effects of the novel neuromuscular blocking drug GW280430A (AV430A) in dogs.
Heerdt PM, Kang R, The' A, Hashim M, Mook RJ Jr, Savarese JJ. Heerdt PM, et al. Anesthesiology. 2004 Apr;100(4):846-51. doi: 10.1097/00000542-200404000-00014. Anesthesiology. 2004. PMID: 15087619